ASCO 23 GU cancer highlight Christopher Sweeney, MBBS Brian Rini, MD CONTACT-3, THOR, PEACE1, 5 yr KN426 and much more. anchor.fm/the-uromigos/e…

Honored to have received an Annual Meeting Research Award from Conquer Cancer, the ASCO Foundation. Looking forward to the ASCO Annual Meeting over the coming days! #ASCO23 #DoubleDocs

It does! Conquer Cancer, the ASCO Foundation ASCO #ASCO23

Getting ready for #ASCO23 day 2 with a 10K run by Lake Michigan.

“PSMA PET will become the new gold standard for imaging of prostate cancer” GU Poster discussion session ASCO #ASCO23

It’s time for the 2023 Medical Student & Resident Abstract Forum. Come check out my poster (22) in S103. #ASCO23 #LatinosInOncology

Very interesting session on Patient-Centric Clinical Trial Design in GU Cancers happening now at #ASCO23

Its time for the #ASCO23 Plenary Session!

PROSPECT:Can we omit RT in selected patients? ☢️Preoperative Chemotherapy with Selective Chemoradiation versus Chemoradiation for Locally Advanced Rectal Cancer: ☢️Yes! There are no differences regarding DFS, OS, pCR, and locoregional reoccurrence! @asco @oncoalert #ASCO23

#ASCO23 Plenary session underway with results of the PROSPECT trial 🎗️Compared neoadjuvant CRT vs FOLFOX 🎗️ Non-inferiority DFS was met 🎗️Path CR and QOL similar 🎗️Neoadjuvant FOLFOX, with selective use CRT, is an effective tx for pts with CT2N+, cT3N-, or cT3N+ rectal cancer

Thanks for sharing such an important point! There are so many side-effects that are not seeing! #LCSM #ASCO23

#ASCO23 Day 4: Prioritizing and Sequencing Therapy for Advanced Prostate Cancer

Thank you again Conquer Cancer, the ASCO Foundation for the Annual Meeting Research Award! #ASCO23 #ConquerCancer

Thx to 🌟ASCO OncMedEdCoP team for creating a home for anyone interested in #OncMedEd. ✨All✨ are welcome regardless of profession, training, specialty, or ASCO membership. Special thx to Jennifer Schwartz MD FASCO and @doctormb1 for our #ASCO23 events! Join us: surveymonkey.com/r/ASCOMedEdCoP

Wonderful presentation by Laurence Albiges Gustave Roussy arguing for doublet v triplet tx. Slides updated to reflect data from Brian Rini, MD Vanderbilt University Medical Center & Thomas Hutson, DO, PharmD, PhD FACP The US Oncology Network presented at #ASCO23 just yesterday (wow!). Come join us in Room E451!

UMN Department of Chemistry’s summer intramural softball was back after a Covid-hiatus! Congrats to The Dynamic Scatterers for taking 3rd place! 🙌🏽✨💪🏽 Tana O'Keefe Mahmoud MA Wilanyi Alvarez Reyes Safia | صفية casey + lots of friends!

Its out! Check out our latest review article “Androgen receptor and estrogen receptor variants in prostate and breast cancers” in the Journal of Steroid Biochemistry and Molecular Biology 🧫 🧬 authors.elsevier.com/a/1izxk3QIyUNZ…

Great discussions happening at the 2024 GRS and GRC on Lipidomics!

Analysis of B7-H3 in >150,000 cancer samples from >50 histologies. A new therapeutic target is born. Congrats to Carly Miller on her first-author paper. Thanks also to Caris Life Services for their collaboration. aacrjournals.org/cancerrescommu…

#AACR25